Cargando…
Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Prevention and risk reduction are important and the identification of specific biomarkers for early diagnosis of HCC represents an active field of research. Increasing evidence indicates that fat accumulation in...
Autores principales: | Rappa, Francesca, Greco, Azzura, Podrini, Christine, Cappello, Francesco, Foti, Michelangelo, Bourgoin, Lucie, Peyrou, Marion, Marino, Arianna, Scibetta, Nunzia, Williams, Roger, Mazzoccoli, Gianluigi, Federici, Massimo, Pazienza, Valerio, Vinciguerra, Manlio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553099/ https://www.ncbi.nlm.nih.gov/pubmed/23372727 http://dx.doi.org/10.1371/journal.pone.0054458 |
Ejemplares similares
-
Correction: Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma
por: Rappa, Francesca, et al.
Publicado: (2013) -
Mutual Antagonism between Circadian Protein Period 2 and Hepatitis C Virus Replication in Hepatocytes
por: Benegiamo, Giorgia, et al.
Publicado: (2013) -
SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation
por: Pazienza, Valerio, et al.
Publicado: (2014) -
Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis
por: Pazienza, Valerio, et al.
Publicado: (2016) -
Phosphorylation within Intrinsic Disordered Region Discriminates Histone Variant macroH2A1 Splicing Isoforms—macroH2A1.1 and macroH2A1.2
por: Giallongo, Sebastiano, et al.
Publicado: (2021)